Back to search
Biliary Tract Cancer (CCA)
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Biliary Tract Cancer (CCA) trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Biliary Tract Cancer (CCA) trials you may qualify forBackground: Cholangiocarcinoma (CCA) is an aggressive cancer of the bile ducts. People with CCA have few treatment options and poor survival. Researchers want…
Hepato-Pancreato-Biliary (HPB) cancers originating in the liver, bile ducts, pancreas, and gall bladder represent a rising global health challenge, with inciden…
This is an exploratory and prospective study, with the research subjects being patients with initially untreated and unresectable biliary tract tumors. The effi…
The study will examine and evaluate the use of extracellular RNA in blood as markers for the diagnosis of liver disease or cancer, and as markers for prediction…
Purpose of the Study: Bile duct cancers are rare and aggressive. About 250 new cases are diagnosed each year in Denmark. These cancers are difficult to detect…
This is a Phase 1 study to assess the safety and efficacy of ELI-002 immunotherapy (a lipid-conjugated immune-stimulatory oligonucleotide \[Amph-CpG-7909\] plus…